About Clinica Onco Star
"Clínica oncológica em São Paulo"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Janssen Research & Development, LLC
3
Loxo Oncology, Inc.
2
Clinical Trials at Clinica Onco Star
During the past decade, Clinica Onco Star conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
2017-07-12
2029-06-24
Active, not recruiting
5,637
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
2019-07-23
2023-12-06
Active, not recruiting
1,100
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
2019-09-16
2023-03-23
Withdrawn
0
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
2019-09-26
2029-09-29
Active, not recruiting
1,064
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
2020-02-17
2027-07-01
Active, not recruiting
250
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
2020-02-11
2026-11-13
Recruiting
400
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
2021-05-10
2024-02-09
Active, not recruiting
2,450
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
2021-11-17
2026-12-29
Recruiting
690
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Onco Star"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Clinica Onco Star
According to Clinical.Site data, the most researched conditions in "Clinica Onco Star" are
"Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Clinica Onco Star" in a lesser frequency.
Clinical Trials Intervention Types at Clinica Onco Star
Most popular intervention types in "Clinica Onco Star" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (3 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Clinica Onco Star
The vast majority of trials in "Clinica Onco Star" are
9 trials for "All" genders.
Clinical Trials Status at Clinica Onco Star
Currently, there are NaN active trials in "Clinica Onco Star".
undefined are not yet recruiting,
3 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Clinica Onco Star,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinica Onco Star, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".